OraSure (OSUR) Company Total Revenue

OraSure Technologies is expanding its rollout of DNA collectors and rapid diagnostics, while the company's aggregate sales revenue on GURU.Markets reflects a period of profit stabilization following the pandemic. The 0.12 mark serves as a key metric for the current trend. High accuracy of home tests and patent protection provide OSUR with significant pricing power.

OraSure Technologies Inc (OSUR) - Revenue and Sales Volume from 07/04/2022 to 11/15/2026

Analytical breakdowns for OraSure Technologies, Inc. (OSUR)

- market value and analyst target forecast:

Market Chart orasure.com|OSUR - Price Target Chart

- market capitalization details:

Market Value OraSure Technologies Inc|OSUR - Total Company Value

- book value of equity indicators:

Accounting Value of a Share OraSure|OSUR - Book Capitalization|Market Capitalization to Book Value Ratio orasure.com|OSUR - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and valuation multiples indicators:

OSUR - Net Income|Future Net Profit OraSure Technologies|OSUR - P/E Multiple|Projected Price to Earnings Ratio OraSure|OSUR - PEG Multiple|Enterprise Value to EBITDA Ratio OraSure Technologies, Inc.|OSUR - Operating profit EBITDA|Earnings per share for the trailing year OraSure|OSUR - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months orasure.com|OSUR - Earnings per share growth in current year|Expected net earnings per share growth next year OraSure Technologies

- company sales and revenue statistics:

OSUR - Company Revenue|Company Projected Revenue orasure.com|OSUR - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio OraSure Technologies, Inc.

Comprehensive company analysis:OraSure Technologies - OSUR

To select high-quality assets, an investor must reconcile the claimed business resilience with actual cash flow. This indicator measures the speed of fund inflows, revealing reporting anomalies or the risk of capital freeze. For OraSure Technologies (OSUR), this reflects the real demand from clinics for rapid tests and genetic devices. Revenue stability confirms the global demand for these products. By analyzing the company's trading revenue, one can assess the objective liquidity of the business.

Key competitors